The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
- PMID: 29688967
- DOI: 10.1097/IGC.0000000000001216
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
Abstract
Background: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer.
Objective: The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide.
Methods: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives.
Results: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.
Comment in
-
Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement.Int J Gynecol Cancer. 2020 Jan;30(1):15. doi: 10.1136/ijgc-2019-000775. Epub 2019 Nov 27. Int J Gynecol Cancer. 2020. PMID: 31780565 No abstract available.
Similar articles
-
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.Radiother Oncol. 2018 Jun;127(3):404-416. doi: 10.1016/j.radonc.2018.03.003. Epub 2018 May 1. Radiother Oncol. 2018. PMID: 29728273
-
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.Virchows Arch. 2018 Jun;472(6):919-936. doi: 10.1007/s00428-018-2362-9. Epub 2018 May 4. Virchows Arch. 2018. PMID: 29725757
-
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.Radiother Oncol. 2023 Jul;184:109682. doi: 10.1016/j.radonc.2023.109682. Epub 2023 May 1. Radiother Oncol. 2023. PMID: 37336614
-
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.Virchows Arch. 2021 Feb;478(2):153-190. doi: 10.1007/s00428-020-03007-z. Virchows Arch. 2021. PMID: 33604759
-
The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).Ceska Gynekol. 2019 Winter;84(1):40-48. Ceska Gynekol. 2019. PMID: 31213057 Review. English.
Cited by
-
Contemporary Review of Adenocarcinoma of the Cervix.Curr Treat Options Oncol. 2024 Nov 13. doi: 10.1007/s11864-024-01254-9. Online ahead of print. Curr Treat Options Oncol. 2024. PMID: 39535688 Review.
-
Nerve-Sparing Laparoscopic Radical Hysterectomy (nsLRH) without Adjuvant Therapy in FIGO Stage IB3 Cervical Cancer Patients: Surgical Technique and Survival Outcomes.Cancers (Basel). 2024 Sep 30;16(19):3355. doi: 10.3390/cancers16193355. Cancers (Basel). 2024. PMID: 39409974 Free PMC article.
-
Time to death from cervical cancer and its predictors in hospitalized patients: a survival approach study in Mato Grosso, Brazil.World J Surg Oncol. 2024 Oct 9;22(1):269. doi: 10.1186/s12957-024-03518-y. World J Surg Oncol. 2024. PMID: 39385163 Free PMC article.
-
The value of contrast-enhanced ultrasound in cervical cancer assessed in comparison with magnetic resonance imaging.Med Pharm Rep. 2024 Jul;97(3):255-262. doi: 10.15386/mpr-2746. Epub 2024 Jul 30. Med Pharm Rep. 2024. PMID: 39234448 Free PMC article.
-
History and Perspectives of Hyperradical, Laterally Extended Parametrectomy (LEP).Ann Surg Oncol. 2024 Oct;31(10):6984-6991. doi: 10.1245/s10434-024-16014-0. Epub 2024 Aug 21. Ann Surg Oncol. 2024. PMID: 39168865
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical